Multi-drug-resistant tuberculosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 15: Line 15:
  | doi = 10.5588/ijtld.14.0192
  | doi = 10.5588/ijtld.14.0192
  | pmid = 25216833
  | pmid = 25216833
}}</ref><ref>{{Cite journal
| author = [[Mahfuza Rifat]], [[Abul Hasnat Milton]], [[John Hall]], [[Christopher Oldmeadow]], [[Md Akramul Islam]], [[Ashaque Husain]], [[Md Wahiduzzaman Akhanda]] & [[Bodrun Naher Siddiquea]]
| title = Development of multidrug resistant tuberculosis in bangladesh: a case-control study on risk factors
| journal = [[PloS one]]
| volume = 9
| issue = 8
| pages = e105214
| year = 2014
| month =
| doi = 10.1371/journal.pone.0105214
| pmid = 25136966
}}</ref>
}}</ref>
*Exposure to a patient with MDR-TB  
*Exposure to a patient with MDR-TB  

Revision as of 13:27, 29 September 2014

Multi-drug-resistant tuberculosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multi-drug-resistant tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multi-drug-resistant tuberculosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multi-drug-resistant tuberculosis risk factors

CDC on Multi-drug-resistant tuberculosis risk factors

Multi-drug-resistant tuberculosis risk factors in the news

Blogs on Multi-drug-resistant tuberculosis risk factors

Directions to Hospitals Treating Multi-drug-resistant tuberculosis

Risk calculators and risk factors for Multi-drug-resistant tuberculosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Risk Factors

The risk factor for developing multi-drug resistant tuberculosis include:[1][2]

  • Exposure to a patient with MDR-TB
  • HIV infection
  • Previous incarceration
  • Failed TB treatment
  • Failure to respond to standard TB treatment
  • Relapse following standard TB treatment

References

  1. Z. Mor, D. Goldblatt, H. Kaidar-Shwartz, N. Cedar, E. Rorman & D. Chemtob (2014). "Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes". The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 18 (10): 1195–1201. doi:10.5588/ijtld.14.0192. PMID 25216833. Unknown parameter |month= ignored (help)
  2. Mahfuza Rifat, Abul Hasnat Milton, John Hall, Christopher Oldmeadow, Md Akramul Islam, Ashaque Husain, Md Wahiduzzaman Akhanda & Bodrun Naher Siddiquea (2014). "Development of multidrug resistant tuberculosis in bangladesh: a case-control study on risk factors". PloS one. 9 (8): e105214. doi:10.1371/journal.pone.0105214. PMID 25136966.

Template:WH Template:WS